Inception Return
(3/23/2012)
|
6.82 %
|
|
YTD Return
|
2.70 %
|
|
NAVPS
(11/24/2023)
|
$11.74
|
|
Change
|
($0.03) / -0.29 %
|
|
|
Growth of $10,000
(As of October 31, 2023)
|
|
MER
|
2.27 %
|
|
Assets ($mil)
|
$1,235.41
|
|
Rank (1Yr)
|
706/1689
|
|
Std Dev (3Yr)
|
10.64 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund seeks to provide a combination of income and capital appreciation by investing primarily in a diversified portfolio of dividend paying equity securities and fixed income securities.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Christopher Chapman, Manulife Investment Management Limited
Sub-Advisor
Michael J. Mattioli, Manulife Investment Management (US) LLC
Daniel S. Janis III, Manulife Investment Management (US) LLC
Thomas C. Goggins, Manulife Investment Management (US) LLC
Dennis F. McCafferty, Manulife Investment Management (US) LLC
Emory (Sandy) W. Sanders, Manulife Investment Management (US) LLC
Kisoo Park, Manulife Investment Management (Hong Kong) Limited
|
|
Asset Allocation
(As of September 30, 2023)
|
Sector Allocation
(As of September 30, 2023)
|
Geographic Allocation
(As of September 30, 2023)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Crown Castle International Corp | US Equity | Real Estate | United States | 0.00% |
| US Dollar | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
| KKR & Co Inc | US Equity | Financial Services | United States | 0.00% |
| Apple Inc | US Equity | Technology | United States | 0.00% |
| American Tower Corp | US Equity | Real Estate | United States | 0.00% |
| Cellnex Telecom SA | International Equity | Telecommunications | European Union | 0.00% |
| Moderna Inc | US Equity | Healthcare | United States | 0.00% |
| Anthem Inc | US Equity | Healthcare | United States | 0.00% |
| Nasdaq Inc | US Equity | Financial Services | United States | 0.00% |
| GSK plc - ADR | International Equity | Healthcare | European Union | 0.00% |
Performance Data
(As of October 31, 2023)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-1.41
|
-5.41
|
-3.66
|
2.70
|
4.22
|
4.76
|
4.26
|
5.89
|
|
Benchmark
|
0.21
|
-2.95
|
-2.10
|
4.24
|
8.02
|
1.35
|
4.50
|
6.61
|
|
Quartile Ranking
|
4
|
4
|
3
|
2
|
2
|
1
|
2
|
1
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-10.12
|
14.03
|
3.93
|
20.31
|
-10.29
|
9.50
|
9.47
|
5.73
|
13.16
|
20.56
|
|
Benchmark
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
12.44
|
18.86
|
|
Quartile Ranking
|
2
|
1
|
4
|
1
|
4
|
1
|
1
|
2
|
1
|
1
|